IP Library Granted Patent US 12,133,495
Granted Patent B2
US 12,133,495 · App. 16/085,838 · Granted Nov 5, 2024

Methods and compositions for producing clonal, non-reduced, non-recombined gametes

Inventors: Marc C Albertsen (Grimes, IA); Tim Wayne Fox (Des Moines, IA); Marissa Simon (Grimes, IA); Mark E Williams (Johnston, IA)
Assignee: PIONEER HI-BRED INTERNATIONAL, INC.
A01H6/4684C07K14/415C12N15/8287
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,133,495
App. No.
16/085,838
Granted
Nov 5, 2024
Kind
B2
Abstract

Methods and compositions useful for avoiding plant meiosis and clonal reproduction through seed are provided herein. The present disclosure provides polynucleotides and related polypeptides of Spo11, Rec8, OSD1-1A, and OSD1-3A and methods and compositions for suppressing their expression level or activity.

Claims (67)

1. A maize plant that produces clonal, non-reduced, non-recombined gametes, wherein the maize plant comprises:

a) eliminated Spo11 activity of an endogenous Spo11 polynucleotide or polypeptide, wherein the Spo11 polynucleotide is selected from the group consisting of:

i. a polynucleotide that encodes the polypeptide of SEQ ID NO:16;

ii. a polynucleotide comprising the sequence set forth in SEQ ID NO:13, and

iii. a polynucleotide having at least 95% sequence identity to SEQ ID NO: 13, wherein the Spo11 polypeptide is selected from the group consisting of:

i. a polypeptide that is encoded by a nucleic acid molecule comprising a nucleotide sequence that is at least 95% identical to SEQ ID NO: 13, wherein the Spo11 activity of the endogenous Spo11 polynucleotide or polypeptide is eliminated by introducing a nucleotide modification into the Spo11 polynucleotide sequence or nucleic acid molecule in part a) to knock-out the endogenous Spo11 polynucleotide;

b) eliminated Rec8 activity of an endogenous Rec8 polynucleotide or polypeptide, wherein Rec8 polynucleotide is selected from the group consisting of:

i. a polynucleotide comprising the sequence set forth in SEQ ID NO:9; and

ii. a polynucleotide having at least 95% sequence identity to SEQ ID NO: 9; wherein the Rec8 polypeptide is selected from the group consisting of:

i. a polypeptide that is encoded by a nucleic acid molecule comprising a nucleotide sequence that is at least 95% identical to SEQ ID NO:9, wherein the Rec8 activity of the endogenous Rec8 polynucleotide or polypeptide is eliminated by introducting a nucleotide modification into REC8 Polyculeotide sequence or nucleic acid molecule in part b) to knock-out the endogenour Rec8 polynucleotide;

c) eliminated OSD1-1A activity of an endogenous OSD1-1A poluynucleotide or polypeptide, wherein OSD1-1A polynuycleotide is selected from the group consisting of:

i. a polynucleotide that encodes the polypeptide of SEQ ID NO:4;

ii. a polynucleotide comprising the sequence set forth in SEQ ID NO:1; and

iii. a polynucleotide having at least 95% sequence identitiy of SEQ ID NO:1; wherein the OSD1-1A polypeptide is selected form the group consisting of:

i. a polypeptide that is encoded by a nucleic acid molecule comprising a nucleotide sequence that is at least 95% identical to SEQ ID NO:1,

wherein the OSD1-1A activity of the endogenous OSD1-1A polynucleotide or polypeptide is eliminated by introducing a nucleotide modification into the OSD1-1A polynucleotide sequence or nucleic acid molecule in part c) to knock-out the endogenous OSD1-1A polynucleotide;

and

d) eliminated OSD1-3A activity of an endogenous OSD1-3A polynucleotide or polypeptide, wherein OSD1-3A polynucleotide is selected from the group consisting of:

i. a polynucleotide that encodes the polypeptide of SEQ ID NO:8;

ii. a polynucleotide comprising the sequence set forth in SEQ ID NO:5; and

iii. a polynucleotide having at least 95% sequence identity to SEQ ID NO:5; wherein the OSD1-3A polypeptide is selected form the group consisting of:

i. a polypeptide that is encoded by a nucleic acid molecule comprising a nucleotide sequence that is at least 95% identical to SEQ ID NO: 5,

wherein the OSD1-3A activity of the endogenous OSD1-3A polynucleotide or polypeptide is eliminated by introducing a nucleotide modification into the OSD1-3A polynucleotide sequence of nucleic acid molecule in part d) to knock-out the endogenous OSD1-3A polynucleotide.

2. The maize plant of claim 1 , wherein the maize plant is a hybrid.

3. The maize plant of claim 1 , wherein the maize plant is a female parent.

4. The maize plant of claim 1 , wherein the introduced nucleotide modification is a deletion, addition, or substitution of one or more nucleotides.

5. The maize plant of claim 1 , wherein the introduced amino acid modification is a deletion, addition, or substitution of one or more amino acids.

6. The maize plant of claim 1 , wherein said the nucleotide modification is introduced by a nuclease selected from the group consisting of: a TALEN, a meganuclease, a zinc finger nuclease, and a CRISPR-associated nuclease.

7. The maize plant of claim 6 , wherein the nucleotide modification is introduced by a Cas9 endonuclease guided by at least one guide RNA.

8. A method for obtaining a maize plant producing clonal, non-reduced, non-recombined gametes, the method comprising:

a) eliminating in the maize plant the Spo11 activity of an endogenous Spo11 polynucleotide or polypeptide, wherein the Spo11 polynucleotide is selected from the group consisting of:

i. a polynucleotide that encodes the polypeptide of SEQ ID NO:16;

ii. a polynucleotide comprising the sequence set forth in SEQ ID NO:13; and

iii. a polynucleotide having at least 95% sequence identity to SEQ ID NO: 13;

wherein the Spo11 polypeptide is selected from the group consisting of:

i. a polypeptide that is encoded by a nucleic acid molecule comprising a nucleotide sequence that is at least 95% identical to SEQ ID NO:13;

b) eliminating in the maize plant the Rec8 activity of an endogenous Rec8 polynucleotide or polypeptide, wherein Rec8 polynucleotide is selected from the group consisting of:

i. a polynucleotide comprising the sequence set forth in SEQ ID NO:9; and

ii. a polynucleotide having at least 95% sequence identity to SEQ ID NO: 9;

wherein the Rec8 polypeptide is selected from the group consisting of:

i. a polypeptide that is encoded by a nucleic acid molecule comprising a nucleotide sequence that is at least 95% identical to SEQ ID NO:9;

c) eliminating in the maize plant the OSD1-1A activity of an endogenous OSD1-1A polynucleotide or polypeptide, wherein OSD1-1A polynucleotide is selected from the group consisting of:

i. a polynucleotide that encodes the polypeptide of SEQ ID NO:4;

ii. a polynucleotide comprising the sequence set forth in SEQ ID NO:1; and

iii. a polynucleotide having at least 95% sequence identity to SEQ ID NO: 1;

wherein the OSD1-1A polypeptide is selected from the group consisting of:

i. a polypeptide that is encoded by a nucleic acid molecule comprising a nucleotide sequence that is at least 95% identical to SEQ ID NO:1;

and

d) eliminating in the maize plant the OSD1-3A activity of an endogenous OSD1-3A polynucleotide or polypeptide, wherein OSD1-3A polynucleotide is selected from the group consisting of:

i. a polynucleotide that encodes the polypeptide of SEQ ID NO:8;

ii. a polynucleotide comprising the sequence set forth in SEQ ID NO:5; and

iii. a polynucleotide having at least 95% sequence identity to SEQ ID NO:5;

wherein the OSD1-3A polypeptide is selected from the group consisting of:

i. a polypeptide that is encoded by a nucleic acid molecule comprising a nucleotide sequence that is at least 95% identical to SEQ ID NO: 5;

wherein the Spo11 activity of the endogenous Spo11 polynucleotide or polypeptide, wherein the Rec8 activity of the endogenous Rec8 polynucleotide or polypeptide, wherein the OSD1-1A activity of the endogenous OSD1-1A polynucleotide or polypeptide, wherein the OSD1-3A activity of the endogenous OSD1-3A polynucleotide or polypeptide, is eliminated by introducing a nucleotide modification into the polynucleotide sequence or nucleic acid molecule in part a), b), c), and d) respectively.

9. The method of claim 8 , wherein the maize plant is a hybrid.

10. The method of claim 8 , wherein the maize plant is a female parent.

11. The method of claim 8 , wherein the nucleotide modification is a deletion, addition, or substitution of one or more nucleotides.

12. The method of claim 8 , wherein the amino acid modification is a deletion, addition, or substitution of one or more amino acids.

13. The method of claim 11 , wherein said the nucleotide modification is introduced by a nuclease selected from the group consisting of: a TALEN, a meganuclease, a zinc finger nuclease, and a CRISPR-associated nuclease.

14. The method of claim 13 , wherein the nucleotide modification is introduced by a Cas9 endonuclease guided by at least one guide RNA.

15. The method of claim 8 , wherein the maize plant is obtained by crossing maize plants that are heterozygous or homozygous for the eliminated endogenous Spo11, Rec8, OSD1-1A or OSD1-3A activity.

16. The method of claim 8 , further comprising obtaining gametes from the female parent, wherein the gametes are clonal, non-reduced, non-recombined.

17. Clonal, non-reduced, non-recombined gametes obtained from the method of claim 8 , wherein the introduced nucleotide modifications into the Spo11, Rec8, OSD1-1A, and OSD1-3A polynucleotide sequences in the maize plant render the gametes clonal, non-reduced, and non-recombined.

18. A maize plant comprising clonal, non-reduced, non-recombined gametes produced from the method of claim 8 .

19. The maize plant of claim 1 , wherein the nucleotide modification is introduced by chemical mutagenesis.

20. The method of claim 8 , wherein the nucleotide modification is introduced by chemical mutagenesis.

Assignments (2)
NUNC PRO TUNC ASSIGNMENT Recorded Nov 29, 2022
From: E.I. DU PONT DE NEMOURS AND COMPANY
To: CORTEVA AGRISCIENCE LLC
Reel/Frame 063141/0155 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2018
From: ALBERTSEN, MARC C; FOX, TIM WAYNE; SIMON, MARISSA KATHARINE; WILLIAMS, MARK E
To: PIONEER HI-BRED INTERNATIONAL, INC.; E.I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 047754/0459 →
Continuity (2)
Provisional Application 62310006 · Mar 18, 2016
Related Publication 20190098858A1 · Apr 4, 2019
Cited By (1)
US 12,446,503